Publications by authors named "M Smolskis"

rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • The text references a correction made to a previously published article, indicated by its DOI (Digital Object Identifier) number.
  • The correction implies that there were inaccuracies or updates needed in the original content of that article.
  • This ensures that the information presented in the scientific literature remains accurate and reliable for readers and researchers.
View Article and Find Full Text PDF

In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.

View Article and Find Full Text PDF

In the United States, clinical trials of COVID-19 vaccines and therapeutics quickly exhausted available clinical research capacity at large medical centers. The NIAID Division of Clinical Research tapped community hospitals to help fill the gap.

View Article and Find Full Text PDF